CAR-T Therapy
BHCT-RD13-02P
Phase 1 small_molecule active
Quick answer
CAR-T Therapy for Peripheral T Cell Lymphoma is a Phase 1 program (small_molecule) at Zhao Weili with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zhao Weili
- Indication
- Peripheral T Cell Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active